Business · 29/05/2025
FDA Revokes Four COVID-19 Emergency Use Authorizations
The FDA has revoked four emergency use authorizations for COVID-19 diagnostic tests, including those for Pfizer's Lucira test kits and a test from MAWD Laboratories, following a request from the authorization holders.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →
Related company profile: Pfizer Inc.Open profile →Explore businesses on Business Maps →